Skip to main content

Table 3 Analyzing the underlying diseases and medications of the patients for delirium

From: Delirium risk factors in hospitalized patient: a comprehensive evaluation of underlying diseases and medications in different wards of a large Urban Hospital Center in Iran

Underlying disease adjusted Drug group adjusted
OR (CI) P-value OR (CI) P-value
Dementia 10.6(1.2-93.9) 0.034 Anti-diabetics 0.5(0.1-2.3) 0.152
Diabetes 2.6(6.9-7.0) 0.072 Anti-hypertensive 0.7(0.1-3.7) 0.432
Hypertension 1.1(3.0-5.3) 0.843 Diuretics 0.4(0.1-1.3) 0.124
Hyperlipidemia Antibiotics 2.3(0.5-9.8) 0.086
Cardiovascular disease 0.9(1.2-3.0) 0.874 Anti-hyperlipidemics 0.6(0.1-2.8) 0.361
Kidney disease 1.1(2.2-6.0) 0.951 Analgesics 1.4(0.3-5.6) 0.463
Liver disease Anti-coagulants 0.3(0.0-1.9) 0.029
Neurologic disease 8.1(6.1-31.2) 0.002 Chemotherapy 0.2(0.1-3.2) 0.078
Malignancies 3.3(8.0-10.1) 0.048 Anti-convulsant 0.2(0.1-3.2) 0.078
Lung disease 1.4(7.2-12.0) 0.737 Sedatives 2.1(0.16-3.5) 0.481
Infectious disease 1.2(5.9-15.0) 0.899 Opioids 0.9 0.861